Epidarex Capital is a transatlantic venture capital firm specializing in early-stage life science investments. The firm focuses on high-growth opportunities in under-ventured markets, often building companies from scratch to address significant unmet medical needs. Epidarex typically invests in Seed and Series A rounds, with occasional participation in later stages.